Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 3Phase EARLY_PHASE1 1

Status

Completed 4Unknown 2Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 3Gastrointestinal 1

Conditions

Breast Neoplasms 3Colorectal Neoplasms 1

Interventions

Cyclophosphamide 741Cisplatin 688Gemcitabine 641Bevacizumab 616Carboplatin 605Paclitaxel 601Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 361Capecitabine 342Filgrastim 333Etoposide 330Dexamethasone 312Irinotecan 309pembrolizumab 282Leucovorin 274Cetuximab 268Cytarabine 242Erlotinib Hydrochloride 231Nivolumab 228Prednisone 227Trastuzumab 225Vincristine 221Bortezomib 221Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Completed × Omacor × Clear all
NCT04268134 2026-05-06

ALTA

University of Michigan Rogel Cancer Center

Phase 2 Completed
77 enrolled 13 charts
Breast

Breast Neoplasms

NCT01661764 2018-06-08

Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer Prevention

Vanderbilt University Medical Center

Phase 2 Completed
141 enrolled 16 charts
Gastrointestinal

Colorectal Neoplasms

NCT01252290 2016-12-16

Breast Cancer Risk Biomarkers in Postmenopausal Women

University of Kansas Medical Center

Phase 2 Completed
35 enrolled 13 charts
Breast

Breast Neoplasms

NCT01252277 2016-07-21

Breast Cancer Risk Biomarkers in Premenopausal Women

University of Kansas Medical Center

Phase 2 Completed
36 enrolled 11 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡